기업 프로필 · Healthcare

Mayinglong Pharmaceutical Group Co Ltd

600993 · 상하이
국가 / 지역
China
상장일
2004년 4월 23일
직원 수
2,544
웹사이트
www.mayinglong.cn
Buffett Score
72/100
우수
시가총액CN¥97.07억
매출 (TTM)CN¥39.29억
EBITDACN¥7.1억
순이익률15.29%
ROE14.16%
PER (TTM)16.2
선행 PER23.42
EPSCN¥1.39
배당수익률3.15%
52주 범위CN¥21.22 – CN¥30.18

데이터 제공: EODHD, 보고 통화 기준 표시. 참고용일 뿐 투자 자문이 아닙니다.

Mayinglong Pharmaceutical Group Co., Ltd., together with its subsidiaries, manufactures and sells Chinese and Western medicines in China and internationally. It operates through three segments: Pharmaceutical Manufacturing; Pharmaceutical Wholesale and Retail; and Medical Services. The company offers functional cosmetics, care products and food, Chinese herbal medicines, and medical devices. It also manufactures, processes, and sells pharmaceutical packaging materials, cosmetics, and Chinese medicines; produces and sells health food; and offers class I and II medical devices, machinery, household goods, electronic products, daily necessities, hygiene products, and disinfection products, as well as road freight transportation services. In addition, the company is involved in the retail and wholesale of medical devices and medicines; imports raw and auxiliary materials, machinery and equipment, instruments and meters, spare parts and related technologies; and exports its products. Mayinglong Pharmaceutical Group Co., Ltd. was founded in 1582 and is headquartered in Wuhan, China.

연혁

준비 중이 섹션은 작성 중입니다. 곧 다시 확인해 주세요.

업계 내 위치

준비 중이 섹션은 작성 중입니다. 곧 다시 확인해 주세요.

이 종목에 대한 리포트가 아직 해당 언어로 없습니다.